Analyst Upgrades – Quest Diagnostics (NYSE:DGX) Stock Gets Upgraded By Credit Suisse Group from Neutral to Outperform

0

Analyst Ratings For Quest Diagnostics (NYSE:DGX)

Today, Quest Diagnostics (NYSE:DGX) stock received an upgrade by Credit Suisse Group from Neutral to Outperform with a price target of $107.00.

Some recent analyst ratings include

  • 2/13/2018-Credit Suisse Group Upgrade from a “Neutral ” rating to a ” Outperform” rating.
  • 2/1/2018-Piper Jaffray Companies Reiterated Rating of Hold.
  • 1/29/2018-Goldman Sachs Group initiated coverage with a Buy rating.
  • 1/16/2018-Canaccord Genuity Reiterated Rating of Buy.
  • 1/4/2018-Evercore ISI initiated coverage with a In rating.

Dividend information for Quest Diagnostics (NYSE:DGX)

Quest Diagnostics (NYSE:DGX) pays an annual dividend of $1.80 with a yield of 1.80% and an average dividend growth of 11.70% based on a 3 Year Average..

Dividend History for Quest Diagnostics (NYSE:DGX)

  • On 2/1/2018 Quest Diagnostics announced a quarterly dividend of $0.50 0.00472500472500473% with an ex dividend date of 4/3/2018 which will be payable on 4/18/2018.
  • On 11/29/2017 Quest Diagnostics announced a quarterly dividend of $0.45 1.83% with an ex dividend date of 1/8/2018 which will be payable on 1/24/2018.
  • On 8/18/2017 Quest Diagnostics announced a quarterly dividend of $0.45 1.72% with an ex dividend date of 10/2/2017 which will be payable on 10/18/2017.
  • On 5/16/2017 Quest Diagnostics announced a quarterly dividend of $0.45 1.71% with an ex dividend date of 7/6/2017 which will be payable on 7/24/2017.
  • On 2/21/2017 Quest Diagnostics announced a quarterly dividend of $0.45 1.88% with an ex dividend date of 4/3/2017 which will be payable on 4/19/2017.
  • On 11/11/2016 Quest Diagnostics announced a quarterly dividend of $0.45 with an ex dividend date of 1/6/2017 which will be payable on 1/25/2017.
  • On 8/17/2016 Quest Diagnostics announced a quarterly dividend of $0.40 1.88% with an ex dividend date of 9/30/2016 which will be payable on 10/19/2016.

Recent Insider Trading Activity For Quest Diagnostics (NYSE:DGX)
Quest Diagnostics (NYSE:DGX) has insider ownership of 1.75% and institutional ownership of 90.22%.

  • On 1/29/2018 Stephen H Rusckowski, Chairman, sold 106,840 with an average share price of $107.00 per share and the total transaction amounting to $11,431,880.00.
  • On 1/24/2018 Catherine T Doherty, SVP, sold 21,294 with an average share price of $104.00 per share and the total transaction amounting to $2,214,576.00.
  • On 1/2/2018 J. E Davis, EVP, sold 63,880 with an average share price of $98.68 per share and the total transaction amounting to $6,303,678.40.
  • On 9/12/2017 Stephen H Rusckowski, Chairman, sold 59,235 with an average share price of $108.16 per share and the total transaction amounting to $6,406,857.60.
  • On 9/11/2017 Daniel Stanzione, Director, sold 40,900 with an average share price of $108.07 per share and the total transaction amounting to $4,420,063.00.
  • On 9/11/2017 Stephen H Rusckowski, CEO, sold 53,933 with an average share price of $108.16 per share and the total transaction amounting to $5,833,393.28.
  • On 9/5/2017 Daniel Stanzione, Director, sold 3,803 with an average share price of $108.01 per share and the total transaction amounting to $410,762.03.

Recent Trading Activity for Quest Diagnostics (NYSE:DGX)
Shares of Quest Diagnostics closed the previous trading session at 100.43 up +1.42 1.43% with 99.87000274658203 shares trading hands.

An ad to help with our costs